IGIBi008-A

Registration Summary:

A P E C

DMD49-50

The cell line is not submitted yet.

(only basic data is shown)

General

Cell Line
hPSCreg name	IGIBi008-A
Cite as:	IGIBi008-A (RRID:CVCL_C3RU)
Alternative name(s)	DMD49-50
Cell line type	Human induced pluripotent stem cell (hiPSC)
Similar lines	No similar lines found.
Last update	19th September 2022
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	CSIR-Institute of Genomics and Integrative Biology (IGIB)
Owner	CSIR-Institute of Genomics and Integrative Biology (IGIB)
Distributors	CSIR-Institute of Genomics and Integrative Biology (IGIB)
External Databases
Cellosaurus	CVCL_C3RU
Wikidata	Q116049569
General Information
Publications	Ahmad I et al. Generation of two induced pluripotent stem cell (iPSC) lines from patients with Duchenne muscular dystrophy (IGIBi006-A and IGIBi008-A) carrying exonic deletions in the dystrophin gene. Stem cell research. 2022 Oct;64:102927. Kim Hyun-Jun et al. Keeping your strength up: induced pluripotent stem cell-based approaches for the treatment and investigation of skeletal muscle disorders. All Life. 2023-12-04. Ahmad I et al. Generation and characterization of two human iPSC lines, IGIBi014-A and IGIBi015-A, from Friedreich's ataxia (FRDA) patients with pathogenic (GAA/TTC)n repeat expansion in first intron of the Frataxin (FXN) gene. Stem cell research. 2024 Feb;74:103289. Ahmad I et al. Generation of two human induced pluripotent stem cell lines, IGIBi012-A and IGIBi013-A from Friedreich's ataxia (FRDA) patients with homozygous GAA repeat expansion in FXN gene. Stem cell research. 2024 Apr;76:103340. Zahra S et al. Generation of an Induced pluripotent stem cell (iPSC) line (IGIBi011-A) from a Spinocerebellar ataxia type 12 gait dominant patient. Stem cell research. 2024 Apr;76:103319. Josvai Mitchell et al. An engineered in vitro model of the human myotendinous junction. Acta Biomaterialia. 2024-05-00. Ahmad I et al. Generation and characterization of iPSC lines from Friedreich's ataxia patient (FRDA) with GAA.TTC repeat expansion in the Frataxin (FXN) gene's first intron (IGIBi016-A) and a non-FRDA healthy control individual (IGIBi017-A). Stem cell research. 2024 Jun;77:103382. Ahmad I et al. Generation and characterization of human-derived induced pluripotent stem cell line (IGIBi010-A) from a patient with neurodegenerative disease phenotype carrying mutation in SQSTM1/p62 gene. Stem cell research. 2024 Oct;80:103520.
* Is the cell line readily obtainable for third parties?	Yes Research use: allowed Clinical use: not allowed Commercial use: not allowed

hIPSC Derivation

General